P Camus S Kudoh M Ebina
10.1038/sj.bjc.6602063
Br J Cancer
2004 Aug;91 Suppl 2(Suppl 2):S18-23.
CC BY
https://pubmed.ncbi.nlm.nih.gov/15340374/
Antineoplastic Combined Chemotherapy Protocols / adverse effects Antineoplastic Combined Chemotherapy Protocols / therapeutic use Carcinoma, Non-Small-Cell Lung / drug therapy Lung Diseases, Interstitial / chemically induced Lung Neoplasms / drug therapy
Antineoplastic Combined Chemotherapy Protocols / adverse effects Antineoplastic Combined Chemotherapy Protocols / therapeutic use Carcinoma, Non-Small-Cell Lung / drug therapy Lung Diseases, Interstitial / chemically induced Lung Neoplasms / drug therapy Case Reports Review Aged Aged, 80 and over Antimetabolites, Antineoplastic / adverse effects Antimetabolites, Antineoplastic / therapeutic use Gefitinib Humans Japan Middle Aged Quinazolines / adverse effects Quinazolines / therapeutic use Respiratory Distress Syndrome Risk Factors Antimetabolites, Antineoplastic Quinazolines Gefitinib
PMC2750811
15340374
Interstitial lung disease associated with drug therapy
2004